Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Feprazone
Cat. No.:
OB0425LY-046
Appearance:
Solid
Purity:
99.88%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Feprazone is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic activities.
Synonyms:
30748-29-9; Prenazone; Fenilprenazone; Phenylprenazone; Methrazone; 3,5-Pyrazolidinedione, 4-(3-methyl-2-buten-1-yl)-1,2-diphenyl-; 1,2-Diphenyl-4-(3-methyl-2-butenyl)-3,5-pyrazolidinedione; 4-(3-Methylbut-2-en-1-yl)-1,2-diphenylpyrazolidine-3,5-dione
CAS No.:
30748-29-9
Compound CID:
35455
Formula:
C20H20N2O2
Formula Weight:
320.39
Specification
Target:
COX; Reactive oxygen species; MMP
Pathway:
Immunology/Inflammation; Metabolic enzyme/Protease; NF-κB
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Feprazone can be used to inhibit adipogenesis and increase lipolysis in differentiated cells, and can be used in studies of atherosclerosis and obesity.
